Interaction of Sleep Duration and Depression on Cardiovascular Disease: a Retrospective Cohort Study
Overview
Affiliations
Background: To assess the interaction of sleep duration and depression on the risk of cardiovascular disease (CVD).
Methods: A total of 13,488 eligible participants were enrolled in this retrospective cohort study eventually. Baseline characteristics were extracted from the China Health and Retirement Longitudinal Study (CHARLS) database, including age, sex, diabetes, high-density lipoprotein (HDL), blood glucose (GLU), glycosylated hemoglobin (GHB) etc. Univariate and multivariate negative binomial regression models were carried out to assess the statistical correlation of sleep duration and depression on CVD separately. Additionally, multivariate negative binomial regression model was used to estimate the interaction of sleep duration and depression on CVD risk.
Results: After adjusting for age, sex, educational background, hypertension, diabetes, dyslipidemia, the use of hypnotics, disability, nap, drinking, deposit, sleep disturbance, HDL, triglyceride, total cholesterol, GLU and GHB, the risk of CVD in participants with the short sleep duration was increased in comparison with the normal sleep duration [relative risk (RR)=1.02, 95% confidence interval (CI):1.01-1.03]; compared to the participants with non-depression, participants suffered from depression had an increased risk of CVD (RR=1.05, 95%CI:1.04-1.06). Additionally, the result also suggested that the interaction between short sleep duration and depression on the risk of CVD was statistically significant in these patients with diabetes and was a multiplicative interaction.
Conclusion: An interaction between short sleep duration and depression in relation to an increased risk of CVD among Chinese middle-aged and elderly individuals was noticed, which may provide a reference that people with diabetes should focus on their sleep duration and the occurrence of depression, and coexisting short sleep duration and depression may expose them to a higher risk of CVD.
Nakada S, Ward J, Strawbridge R, Welsh P, Celis-Morales C, Ho F BMC Med. 2025; 23(1):73.
PMID: 39915848 PMC: 11804096. DOI: 10.1186/s12916-025-03915-4.
Lai Y, Zhang X, Dong H, Li M Front Psychiatry. 2024; 15:1487550.
PMID: 39479594 PMC: 11521870. DOI: 10.3389/fpsyt.2024.1487550.
Hallab A Lipids Health Dis. 2024; 23(1):320.
PMID: 39342373 PMC: 11439313. DOI: 10.1186/s12944-024-02302-x.
Jiang H, Zhang X, Liang J J Pain Res. 2024; 17:2777-2787.
PMID: 39220223 PMC: 11363950. DOI: 10.2147/JPR.S471401.
A Mendelian randomization study of the effect of mental disorders on cardiovascular disease.
Yu Y, Yang X, Wu J, Hu G, Bai S, Yu R Front Cardiovasc Med. 2024; 11:1329463.
PMID: 38887450 PMC: 11180800. DOI: 10.3389/fcvm.2024.1329463.